Stable 5,6-epoxyeicosatrienoic acid analog relaxes coronary arteries through potassium channel activation

Hypertension

Volumn 45, Issue 4 SUPPL., 2005, Pages 681-686

  Yang, Wenqi ^a   Gauthier, Kathryn M ^a   Reddy, L Manmohan ^b   Sangras, Bhavani ^b   Sharma, Kamalesh K ^b   Nithipatikom, Kasem ^a   Falck, John R ^b   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Arachidonic acids; Cyclooxygenase; Endothelium derived factors

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 (PENTADECA 3,6,9 TRIENYLOXY)PENTANOIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; ARACHIDONIC ACID; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYTOCHROME P450; GLIBENCLAMIDE; IBERIOTOXIN; INDOMETACIN; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG; VALERIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY; COW; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

8,11,14-EICOSATRIENOIC ACID; ADENOSINE TRIPHOSPHATE; ANIMALS; CATTLE; CORONARY VESSELS; DRUG STABILITY; ELECTRIC CONDUCTIVITY; GLYBURIDE; INDOMETHACIN; PATCH-CLAMP TECHNIQUES; PENTANOIC ACIDS; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; VASODILATION;

EID: 15744402253     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000153790.12735.f9     Document Type: Conference Paper

References (34)

1. McGiff JC. Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol. 1991;31:339-369.
2. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
3. Oltman CL, Weintraub NL, VanRollins M, Dellsperger KC. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res. 1998;83:932-939.
4. Hildebrandt E, Albanesi JP, Falck JR, Campbell WB. Regulation of calcium influx and catecholamine secretion in chromaffin cells by a cytochrome P450 metabolite of arachidonic acid. J Lipid Res. 1995;36:2599-2608.
5. Junier MP, Dray F, Blair I, Capdevila J, Dishman E, Falck JR, Ojeda SR. Epoxygenase products of arachidonic acid are endogenous constituents of the hypothalamus involved in D2 receptor-mediated, dopamine-induced release of somatostatin. Endocrinology. 1990;126:1534-1540.
6. Imig JD. Epoxygenase metabolites. Epithelial and vascular actions. Mol Biotechnol. 2000;16:233-251.
7. Gebremedhin D, Ma YH, Falck JR, Roman RJ, VanRollins M, Harder DR. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol. 1992;263:H519-H525.
8. Zeldin DC, Shouzou W, Falck JR, Hammock BD, Snapper JR, Capdevila JH. Metabolism of epoxyeicosatrienoic acids by cytosolic epoxides hydrolase: substrate structural determinants of asymmetric catalysis. Arch Biochem Biophys. 1995;316:443-451.
9. Fang X, Weintraub NL, Oltman CL, Stoll LL, Kaduce TL, Harmon S, Dellsperger KC, Morisseau C, Hammock BD, Spector AA. Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide. Am J Physiol. 2002;283:H2306-H2314.
10. VanRollins M, Kaduce TL, Knapp HR, Spector AA. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells. J Lipid Res. 1993;34:1931-1942.
11. VanderNoot VA, VanRollins M. Capillary electrophoresis of cytochrome P-450 epoxygenase metabolites of arachidonic acid. 1. Resolution of regioisomers. Anal Chem. 2002;74:5859-5865.
12. Fulton D, Falck JR, McGiff JC, Carroll MA, Quilley J. A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol. J Lipid Res. 1998;39:1713-1721.
13. Oliw EH. Metabolism of 5(6)-expoxyeicosatrienoic acid by ram seminal vesicles. Formation of novel prostaglandin E1 metabolites. Biochim Biophys Acta. 1984;793:408-415.
14. Oliw EH. Metabolism of 5(6)oxidoeicosatrienoic acid by ram seminal vesicles. Formation of two stereoisomers of 5-hydroxyprostaglandin II. J Biol Chem. 1984;259:2716-2721.
15. Carroll MA, Balazy M, Margiotta P, Falck JR, McGiff JC. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J Biol Chem. 1993;268:12260-12266.
16. Rosolowsky M, Campbell WB. Role of PGI2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 1993;264:H327-H335.
17. Ca, channels. Am J Physiol. 2002;282:H1656-H1664.
18. Nithipatikom K, Grall AJ, Holmes BB, Harder DR, Falck JR, Campbell WB. Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid. Anal Biochem. 2001;298:327-336.
19. Carroll MA, Garcia MP, Falck JR, McGiff JC. 5,6-epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat. Circ Res. 1990;67:1082-1088.
20. Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthesh SC. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol. 1990;259:H1171-H1177.
21. Zucker B, Leffler CW. PTX-sensitive G-proteins and permissive action of prostacyclin in newborn pig cerebral circulation. Am J Physiol. 1998;275:H259-H263.
22. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR, Campbell WB. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res. 2002;90:1028-1036.
23. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401:493-497.
24. Popp R, Bauersachs J, Hecker M, Fleming I, Busse R. A transferable, B-napthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J Physiol. 1996;497:699-709.
25. Gebremedhin D, Harder DR, Pratt PF, Campbell WB. Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J Vasc Res. 1998;35:274-284.
26. Fulton D, Mahboubi K, McGiff JC, Quilley J. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br J Pharmacol. 1995;114:99-102.
27. Jackson WF, Konig A, Dambacher T, Busse R. Prostacyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels. Am J Physiol. 1993;264:H238-H243.
28. Schubert R, Serebryakov VN, Mewes H, Hopp HH. Iloprost dilates rat small arteries: role of K(ATP)- and K(Ca)-channel activation by cAMP-dependent protein kinase. Am J Physiol. 1997;272:H1147-H1156.
29. Smith W. Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. Ann Rev Physiol. 1986;48:251-262.
30. Imig JD, Navar LG, Roman RJ, Reddy KK, Falck JR. Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol. 1996;7:2364-2370.
31. Stephenson AH, Sprague RS, Losapio JL, Lonigro AJ. 5,6-EET dilates large extralobar PA segments in a COX-dependent manner, in the intact rabbit lung 5,6-EET produces constriction that requires synthesis of a COX-dependent agonist of the TP receptor other than TX. Am J Physiol. 2003;284:H2153-H2161.
32. Revtyak GE, Johnson AR, Campbell WB. Cultured bovine coronary arterial endothelial cells synthesize HETEs and prostacyclin. Am J Physiol. 1988;254:C8-C19.
33. Sakairi Y, Jacobson HR, Noland TD, Capdevila JH, Falck JR, Breyer MD. 5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis. Am J Physiol. 1995;268:F931-F939.
34. Gauthier KM, Falck JR, Reddy LM, Campbell WB. 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries. Pharmacol Res. 2004;49:515-524.